There continues to be a great deal...

There continues to be a great deal interest within industry and FDA about the coming events of the GMPs. Discussion clumps have been spawned within professional organizations and at FDA to reevaluate the aging GMP and associated guidance documents to make sure that the government does not impede technological progres focuses its resources effectively, and sustains its mandate to protect the public. Although this direction is largely fueled by means of FDA's budgetary constraints, good things happen when we are reminded to focus in succession the essentials.

The at hand struggle within industry and among regulators is